IR

Growth Strategy

Growth Strategy

Medium-Term Business Plan

At the financial results briefing for the fiscal year ended March 31, 2026, the Group announced its Medium-Term Business Plan targeting Adjusted EBITA (Operating profit + amortization of goodwill (including amortization of intangible assets recognized through purchase price allocation (PPA)) + M&A-related expenses (including advisory fees and due diligence costs)) of 90.0 billion yen for the fiscal year ending March 31, 2030.

In addition to further strengthening existing businesses such as ZOZOTOWN, the Company aims to create new revenue pillars outside of ZOZOTOWN.

The Group positions its existing domestic businesses, including ZOZOTOWN, as the “More Fashion” domain; businesses in fashion-adjacent domestic markets targeted for future expansion as the “Near Fashion” domain; and businesses centered on LYST and ZOZOFIT aimed at expanding earnings in North America and Europe as the “Global” domain. The Group aims to achieve Adjusted EBITA of 80.0 billion yen in the “More Fashion” domain, and 5.0 billion yen each in the “Near Fashion” and “Global” domains, for a total of 90.0 billion yen across all businesses in the fiscal year ending March 31, 2030.

In the “More Fashion” domain centered on ZOZOTOWN, the Group will strengthen initiatives aimed at providing unique added value to both users and brands through measures such as accelerating the acquisition of new users, proactively attracting new brands, and leveraging the extensive data held by ZOZO.

In the “Near Fashion” domain, the Group views in-house development, business alliances, and capital alliances as drivers of earnings growth, and aims to contribute to earnings by offering multiple services beyond ZOZOTOWN that offer purchasing experiences in fashion-adjacent areas likely to resonate with ZOZOTOWN users.

In the “Global” domain, the Group intends to expand overseas earnings primarily in North America and Europe by leveraging ZOZO’s technologies. In addition to enhancing the functionality of ZOZOFIT, which is primarily offered in the United States, and expanding its geographic reach, the Group also aims to generate earnings contributions from LYST, which became a consolidated subsidiary in May 2025, by utilizing ZOZO’s expertise and know-how.